Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
CASE REPORTS
Successful Treatment with High-dose Steroids for Acute Exacerbation of Idiopathic Pulmonary Fibrosis Triggered by COVID-19
Norihito OmoteYoshihiro KanemitsuTakahiro InoueToshiyuki YonezawaTakuji IchihashiYuichiro ShindoKoji SakamotoAkira AndoAtsushi SuzukiAkio NiimiSatoru ItoKazuyoshi ImaizumiNaozumi Hashimoto
Author information
JOURNAL OPEN ACCESS

2022 Volume 61 Issue 2 Pages 233-236

Details
Abstract

We herein report a case of acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) triggered by COVID-19. An 87-year-old woman tested positive for COVID-19 on a polymerase chain reaction test, and computed tomography revealed ground-glass opacity (GGO) superimposed on a background pattern consistent with usual interstitial pneumonia. Considering these data, we diagnosed her with AE-IPF. She experienced worsening of dyspnea and expansion of the GGO. Therefore, we introduced high-dose steroids (methylprednisolone 250 mg/day for 3 days). After the treatment, the pulmonary infiltrates improved. She was discharged from our hospital without severe disability. High-dose steroids can be a viable treatment option for AE-IPF triggered by COVID-19.

Content from these authors
© 2022 by The Japanese Society of Internal Medicine
Previous article Next article
feedback
Top